RMTI Rockwell Medical Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: RMTI

Price (delayed)

$1.535

Market cap

$45.03M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.37

Enterprise value

$49.48M

Rockwell Medical is a biopharmaceutical company dedicated to transforming anemia management in a wide variety of therapeutic areas and across the globe, improving the lives of very sick patients. The ...

Highlights
The gross profit has soared by 113% YoY and by 6% QoQ
RMTI's gross margin has soared by 86% YoY and by 3% QoQ
RMTI's quick ratio is up by 32% QoQ but it is down by 17% YoY
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.rockwellmed.com
Peers: ICUI BAX ABT NEPH

Key stats

What are the main financial stats of RMTI
Market
Shares outstanding
29.33M
Market cap
$45.03M
Enterprise value
$49.48M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
2.05
Price to sales (P/S)
0.43
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.59
Earnings
Revenue
$83.61M
EBIT
-$6.14M
EBITDA
-$2.68M
Free cash flow
-$9.7M
Per share
EPS
-$0.37
Free cash flow per share
-$0.42
Book value per share
$0.75
Revenue per share
$3.58
TBVPS
$1.74
Balance sheet
Total assets
$52.17M
Total liabilities
$30.88M
Debt
$13.44M
Equity
$21.29M
Working capital
$12.13M
Liquidity
Debt to equity
0.63
Current ratio
1.73
Quick ratio
1.31
Net debt/EBITDA
-1.66
Margins
EBITDA margin
-3.2%
Gross margin
10.4%
Net margin
-10.1%
Operating margin
-8%
Efficiency
Return on assets
-18.4%
Return on equity
-52%
Return on invested capital
-22.2%
Return on capital employed
-17.3%
Return on sales
-7.3%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

RMTI stock price

How has the Rockwell Medical stock price performed over time
Intraday
5.14%
1 week
3.02%
1 month
-9.71%
1 year
-47.79%
YTD
-18.78%
QTD
-7.53%

Financial performance

How have Rockwell Medical's revenue and profit performed over time
Revenue
$83.61M
Gross profit
$8.7M
Operating income
-$6.67M
Net income
-$8.44M
Gross margin
10.4%
Net margin
-10.1%
The gross profit has soared by 113% YoY and by 6% QoQ
RMTI's gross margin has soared by 86% YoY and by 3% QoQ
The company's operating margin has surged by 65% YoY and by 20% QoQ
The company's net margin has surged by 61% YoY and by 12% QoQ

Growth

What is Rockwell Medical's growth rate over time

Valuation

What is Rockwell Medical stock price valuation
P/E
N/A
P/B
2.05
P/S
0.43
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.59
The EPS has soared by 72% YoY and by 8% from the previous quarter
RMTI's price to book (P/B) is 59% lower than its 5-year quarterly average of 4.8 and 47% lower than its last 4 quarters average of 3.7
RMTI's equity has surged by 51% year-on-year
RMTI's price to sales (P/S) is 68% lower than its 5-year quarterly average of 1.3 and 49% lower than its last 4 quarters average of 0.8
Rockwell Medical's revenue has increased by 15% YoY and by 3.4% from the previous quarter

Efficiency

How efficient is Rockwell Medical business performance
RMTI's return on equity has surged by 68% year-on-year and by 19% since the previous quarter
The ROS has soared by 68% YoY and by 23% from the previous quarter
The return on invested capital has surged by 53% year-on-year and by 16% since the previous quarter
Rockwell Medical's return on assets has surged by 51% YoY and by 12% QoQ

Dividends

What is RMTI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for RMTI.

Financial health

How did Rockwell Medical financials performed over time
Rockwell Medical's total assets is 69% more than its total liabilities
RMTI's quick ratio is up by 32% QoQ but it is down by 17% YoY
RMTI's current ratio is up by 31% QoQ but it is down by 14% YoY
The company's debt is 37% lower than its equity
RMTI's equity has surged by 51% year-on-year
The debt to equity has contracted by 46% YoY and by 9% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.